Viewing Study NCT00226967


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-04 @ 6:00 PM
Study NCT ID: NCT00226967
Status: COMPLETED
Last Update Posted: 2020-01-27
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Stress, Diurnal Cortisol, and Breast Cancer Survival
Sponsor: Stanford University
Organization:

Study Overview

Official Title: Stress, Diurnal Cortisol, and Breast Cancer Survival
Status: COMPLETED
Status Verified Date: 2019-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to learn about the effects of stress on hormones, the relationship between these hormones and cancer progression.
Detailed Description: The purpose of this study is to investigate stress and tonic activation of diurnal cortisol in aging metastatic breast cancer patients; feedback inhibition \& activation of cortisol; and stress-induced phasic activation of cortisol.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
BRSADJ0006 OTHER OnCore View
76389 OTHER Stanford University Alternate IRB Approval Number View